143 related articles for article (PubMed ID: 25710003)
1. Immunodiagnosis of canine visceral leishmaniasis using mimotope peptides selected from phage displayed combinatorial libraries.
Toledo-Machado CM; de Avila RA; NGuyen C; Granier C; Bueno LL; Carneiro CM; Menezes-Souza D; Carneiro RA; Chávez-Olórtegui C; Fujiwara RT
Biomed Res Int; 2015; 2015():401509. PubMed ID: 25710003
[TBL] [Abstract][Full Text] [Related]
2. Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.
Costa LE; Lima MI; Chávez-Fumagalli MA; Menezes-Souza D; Martins VT; Duarte MC; Lage PS; Lopes EG; Lage DP; Ribeiro TG; Andrade PH; de Magalhães-Soares DF; Soto M; Tavares CA; Goulart LR; Coelho EA
Clin Vaccine Immunol; 2014 Jan; 21(1):96-106. PubMed ID: 24256622
[TBL] [Abstract][Full Text] [Related]
3. A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.
Lage DP; Martins VT; Duarte MC; Costa LE; Garde E; Dimer LM; Kursancew AC; Chávez-Fumagalli MA; de Magalhães-Soares DF; Menezes-Souza D; Roatt BM; Machado-de-Ávila RA; Soto M; Tavares CA; Coelho EA
Parasitol Res; 2016 Apr; 115(4):1649-58. PubMed ID: 26782811
[TBL] [Abstract][Full Text] [Related]
4. Immunodiagnosis of human and canine visceral leishmaniasis using recombinant Leishmania infantum Prohibitin protein and a synthetic peptide containing its conformational B-cell epitope.
Rodrigues MR; Santos LMO; Miyazaki CK; Martins VT; Ludolf FR; Kursancew AC; Ramos FF; Dias DS; Oliveira JS; Vieira PMA; Roatt BM; Machado de Ávila RA; Gonçalves DU; Menezes-Souza D; Coelho EAF; Duarte MC
J Immunol Methods; 2019 Nov; 474():112641. PubMed ID: 31400411
[TBL] [Abstract][Full Text] [Related]
5. Advances in flow cytometric serology for canine visceral leishmaniasis: diagnostic applications when distinct clinical forms, vaccination and other canine pathogens become a challenge.
Andrade RA; Silva Araújo MS; Reis AB; Gontijo CM; Vianna LR; Mayrink W; Martins-Filho OA
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):79-86. PubMed ID: 19046772
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP® CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis.
Grimaldi G; Teva A; Ferreira AL; dos Santos CB; Pinto Id; de-Azevedo CT; Falqueto A
Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):54-9. PubMed ID: 22137538
[TBL] [Abstract][Full Text] [Related]
7. Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasis.
Costa LE; Salles BCS; Santos TTO; Ramos FF; Lima MP; Lima MIS; Portela ÁSB; Chávez-Fumagalli MA; Duarte MC; Menezes-Souza D; Machado-de-Ávila RA; Silveira JAG; Magalhães-Soares DF; Goulart LR; Coelho EAF
Microb Pathog; 2017 Sep; 110():14-22. PubMed ID: 28629727
[TBL] [Abstract][Full Text] [Related]
8. Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes.
Toledo-Machado CM; Bueno LL; Menezes-Souza D; Machado-de-Avila RA; Nguyen C; Granier C; Bartholomeu DC; Chávez-Olórtegui C; Fujiwara RT
Parasit Vectors; 2015 Feb; 8():133. PubMed ID: 25889286
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of the DPP(®) CVL rapid test for canine serodiagnosis in area of visceral leishmaniasis.
Laurenti MD; de Santana Leandro MV; Tomokane TY; De Lucca HR; Aschar M; Souza CS; Silva RM; Marcondes M; da Matta VL
Vet Parasitol; 2014 Oct; 205(3-4):444-50. PubMed ID: 25257505
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serological assays for the diagnosis of canine visceral leishmaniasis in animals presenting different clinical manifestations.
Ferreira Ede C; de Lana M; Carneiro M; Reis AB; Paes DV; da Silva ES; Schallig H; Gontijo CM
Vet Parasitol; 2007 May; 146(3-4):235-41. PubMed ID: 17403582
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
Coelho EA; Costa LE; Lage DP; Martins VT; Garde E; de Jesus Pereira NC; Lopes EG; Borges LF; Duarte MC; Menezes-Souza D; de Magalhães-Soares DF; Chávez-Fumagalli MA; Soto M; Tavares CA
Vet Parasitol; 2016 Jan; 215():63-71. PubMed ID: 26790739
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of recombinant Leishmania donovani virulence factor A2 (recLdVFA2) and canine leishmaniasis diagnosis using a derived synthetic bi-epitope.
Mendes TM; Roma EH; Costal-Oliveira F; Dhom-Lemos LC; Toledo-Machado CM; Bruna-Romero O; Bartholomeu DC; Fujiwara RT; Chávez-Olórtegui C
PLoS Negl Trop Dis; 2017 May; 11(5):e0005562. PubMed ID: 28557986
[TBL] [Abstract][Full Text] [Related]
13. High-throughput analysis of synthetic peptides for the immunodiagnosis of canine visceral leishmaniasis.
Faria AR; Costa MM; Giusta MS; Grimaldi G; Penido ML; Gazzinelli RT; Andrade HM
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1310. PubMed ID: 21931874
[TBL] [Abstract][Full Text] [Related]
14. Multi-antigen print immunoassay (MAPIA)-based evaluation of novel recombinant Leishmania infantum antigens for the serodiagnosis of canine visceral leishmaniasis.
de Oliveira IQ; Silva RA; Sucupira MV; da Silva ED; Reis AB; Grimaldi G; Fraga DB; Veras PS
Parasit Vectors; 2015 Jan; 8():45. PubMed ID: 25616448
[TBL] [Abstract][Full Text] [Related]
15. Mapping B-cell epitopes for the peroxidoxin of Leishmania (Viannia) braziliensis and its potential for the clinical diagnosis of tegumentary and visceral leishmaniasis.
Menezes-Souza D; Mendes TA; Nagem RA; Santos TT; Silva AL; Santoro MM; de Carvalho SF; Coelho EA; Bartholomeu DC; Fujiwara RT
PLoS One; 2014; 9(6):e99216. PubMed ID: 24921246
[TBL] [Abstract][Full Text] [Related]
16. Accuracy and reproducibility of a rapid chromatographic immunoassay for the diagnosis of canine visceral leishmaniasis in Brazil.
Schubach EY; Figueiredo FB; Romero GA
Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):568-74. PubMed ID: 25015665
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of the HSP83.1 protein of Leishmania braziliensis discloses novel targets for immunodiagnosis of tegumentary and visceral clinical forms of leishmaniasis.
Menezes-Souza D; Mendes TA; Gomes Mde S; Reis-Cunha JL; Nagem RA; Carneiro CM; Coelho EA; Galvão LM; Fujiwara RT; Bartholomeu DC
Clin Vaccine Immunol; 2014 Jul; 21(7):949-59. PubMed ID: 24807053
[TBL] [Abstract][Full Text] [Related]
18. Antigens and their diagnostic performance for Canine Visceral Leishmaniasis: A critical review.
Barbosa de Castro R; Badaró de Moraes JV; Costa Bressan G; de Souza Vasconcellos R; Silva-Júnior A; Lopes Rangel Fietto J
Vet Parasitol; 2022 Jan; 301():109638. PubMed ID: 34920304
[TBL] [Abstract][Full Text] [Related]
19. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
Martins VT; Duarte MC; Chávez-Fumagalli MA; Menezes-Souza D; Coelho CS; de Magalhães-Soares DF; Fernandes AP; Soto M; Tavares CA; Coelho EA
Parasit Vectors; 2015 Jul; 8():363. PubMed ID: 26160291
[TBL] [Abstract][Full Text] [Related]
20. Improving serodiagnosis of human and canine leishmaniasis with recombinant Leishmania braziliensis cathepsin l-like protein and a synthetic peptide containing its linear B-cell epitope.
Menezes-Souza D; Mendes TA; Gomes Mde S; Bartholomeu DC; Fujiwara RT
PLoS Negl Trop Dis; 2015 Jan; 9(1):e3426. PubMed ID: 25569432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
